clonidine has been researched along with Alcohol Abuse in 44 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Excerpt | Relevance | Reference |
---|---|---|
"In this study, we evaluated the effect of intrathecal and oral clonidine as supplements to spinal anesthesia with lidocaine in patients at risk of postoperative alcohol withdrawal syndrome (AWS)." | 5.11 | Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study. ( Axelsson, K; Berggren, L; Dobrydnjov, I; Holmström, B; Samarütel, J, 2004) |
"Thirteen of these patients with alcohol abuse were treated postoperatively with IV clonidine for prevention of alcohol withdrawal syndrome." | 2.68 | Postoperative alpha 2-adrenergic stimulation attenuates protein catabolism. ( Goeters, C; Kuhmann, M; Mertes, N; Zander, JF, 1996) |
"Alprazolam was significantly more efficacious than both clonidine and placebo in decreasing withdrawal symptoms." | 2.67 | Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. ( Adinoff, B, 1994) |
"Lofexidine (L) was compared to placebo (P) in a random double blind placebo controlled study of 23 healthy alcoholics in withdrawal." | 2.66 | Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment. ( Cushman, P; Sowers, JR, 1989) |
"In a doubl-blind study, patients receiving a rapidly falling dosage of clonidine recovered about 1 day faster from the symptoms of moderately severe alcohol withdrawal than patients receiving placebo." | 2.64 | Clonidine in alcohol withdrawal. ( Björkqvist, SE, 1975) |
"Clonidine has provided a nonaddicting solution to an ancient problem, opiate withdrawal without opiates." | 2.37 | Clonidine. ( Gold, MS; Roehrich, H, 1987) |
"Alcohol dependence has been associated with reduced function of serotonin, dopamine as well as noradrenaline activities in several neuroendocrine studies." | 1.38 | Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals. ( Balldin, J; Berggren, U; Berglund, KJ; Blennow, K; Engel, JA; Fahlke, C; Zetterberg, H, 2012) |
"Pretreatment with lofexidine (0." | 1.33 | Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. ( Funk, D; Harding, S; Juzytsch, W; Lê, AD; Shaham, Y, 2005) |
"A total of seven male patients with alcohol dependence according to DSM-IV were assessed for the postsynaptic alpha-2-receptor function with the CLON/GH test (2." | 1.31 | Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence. ( Balldin, J; Berggren, U; Fahlke, C; Norrby, A; Zachrisson, O, 2000) |
" Drug was most often given on a fixed dosing schedule with additional medication "as needed" (52% of the programs)." | 1.29 | Alcohol withdrawal: a nationwide survey of inpatient treatment practices. ( Friedman, LS; Mayo-Smith, MF; Saitz, R, 1995) |
"Finally it is suggested that insomnia and the loss of REM sleep may also contribute to the onset of the condition." | 1.27 | [Changes in the circadian rhythm of urinary cyclic adenosine monophosphate during the alcoholic withdrawal syndrome and related neurobiological correlations]. ( Cedaro, P; Di Piazza, V; Geatti, O; Lattuada, L; Marchetti, E; Nardoni, A, 1985) |
"Clonidine was found to be remarkably effective in alleviating various alcohol abstinence signs in a chronic alcoholic." | 1.27 | Clonidine in alcohol withdrawal: a clinical report. ( Kulkarni, GK; Kulkarni, SK; Parale, MP, 1987) |
"bolus of clonidine (1." | 1.27 | Clonidine in alcohol withdrawal: a pilot study of differential symptom responses following i.v. clonidine. ( Glue, P; Nutt, D, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (40.91) | 18.7374 |
1990's | 11 (25.00) | 18.2507 |
2000's | 9 (20.45) | 29.6817 |
2010's | 6 (13.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mills, WD | 1 |
Greenhaw, RM | 1 |
Wang, JMP | 1 |
Haass-Koffler, CL | 1 |
Swift, RM | 1 |
Leggio, L | 1 |
Albertson, TE | 1 |
Chenoweth, J | 1 |
Ford, J | 1 |
Owen, K | 1 |
Sutter, ME | 1 |
Arora, S | 1 |
Vohora, D | 1 |
Fahlke, C | 4 |
Berggren, U | 4 |
Berglund, KJ | 1 |
Zetterberg, H | 1 |
Blennow, K | 1 |
Engel, JA | 1 |
Balldin, J | 5 |
Tonner, PH | 1 |
Paris, A | 1 |
Eriksson, M | 1 |
Sundkler, A | 1 |
Hensel, M | 1 |
Kox, WJ | 1 |
Huitink, J | 1 |
Buitelaar, D | 1 |
Dobrydnjov, I | 1 |
Axelsson, K | 1 |
Berggren, L | 1 |
Samarütel, J | 1 |
Holmström, B | 1 |
Lê, AD | 1 |
Harding, S | 1 |
Juzytsch, W | 1 |
Funk, D | 1 |
Shaham, Y | 1 |
Matussek, N | 1 |
Martin, PR | 1 |
Ebert, MH | 1 |
Gordon, EK | 1 |
Linnoila, M | 2 |
Kopin, IJ | 1 |
Wilkins, AJ | 1 |
Jenkins, WJ | 1 |
Steiner, JA | 1 |
Gorelick, DA | 1 |
Strickland, RA | 1 |
Berge, KH | 1 |
Adinoff, B | 2 |
De Marinis, L | 1 |
Mancini, A | 1 |
Fiumara, C | 1 |
Conte, G | 1 |
Iacona, T | 1 |
Ianiri, L | 1 |
Zeppetelli, E | 1 |
Gobbi, G | 1 |
Tempesta, E | 1 |
Covey, LS | 1 |
Glassman, AH | 1 |
Stetner, F | 1 |
Becker, J | 1 |
Saitz, R | 1 |
Friedman, LS | 1 |
Mayo-Smith, MF | 1 |
Mertes, N | 1 |
Goeters, C | 1 |
Kuhmann, M | 1 |
Zander, JF | 1 |
Mrazek, M | 1 |
Menges, C | 1 |
Steffes, J | 1 |
Thelen, B | 1 |
Erkwoh, R | 1 |
Norrby, A | 1 |
Zachrisson, O | 1 |
Soyka, M | 2 |
Horak, M | 2 |
Björkqvist, SE | 1 |
Dennison, SJ | 1 |
Bokström, K | 1 |
Purschke, R | 1 |
Glue, P | 4 |
Sellman, JD | 2 |
Nicholls, MG | 2 |
Abbott, R | 1 |
Joyce, PR | 2 |
Nutt, DJ | 2 |
Müller, N | 1 |
Hoehe, M | 1 |
Klein, HE | 1 |
Nieberle, G | 1 |
Kapfhammer, HP | 1 |
May, F | 1 |
Müller, OA | 1 |
Fichter, M | 1 |
Cushman, P | 2 |
Sowers, JR | 1 |
Robinson, BJ | 1 |
Robinson, GM | 1 |
Maling, TJ | 1 |
Johnson, RH | 1 |
Mefford, I | 1 |
Nutt, D | 3 |
Molyneux, S | 1 |
Clark, E | 1 |
Peachey, JE | 1 |
Nardoni, A | 1 |
Di Piazza, V | 1 |
Marchetti, E | 1 |
Geatti, O | 1 |
Cedaro, P | 1 |
Lattuada, L | 1 |
Roehrich, H | 1 |
Gold, MS | 1 |
Kulkarni, SK | 1 |
Parale, MP | 1 |
Kulkarni, GK | 1 |
Linder, R | 1 |
Garcia, A | 1 |
Svensson, TH | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Examination of Palonosetron and Hydroxyzine Pre-treatment as a Possible Method to Reduce the Objective Signs of Experimentally-induced Acute Opioid Withdrawal in Humans: a Double-blind, Randomized, Placebo-controlled Crossover Study[NCT00661674] | 10 participants (Actual) | Interventional | 2008-04-30 | Completed | |||
Phenobarbital Versus Ativan for Refractory Alcohol Withdrawal Treatment in the Intensive Care Unit[NCT04156464] | Phase 4 | 142 participants (Anticipated) | Interventional | 2020-07-06 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"The OOWS is a 13-item instrument documenting physically observable signs of withdrawal, which are rated as present (1) or absent (0) during the observation period. Maximum score possible = 13, minimum score possible = 0. T=15 minutes post naloxone administration coordinates with T = 180 (min) for the entire study session.~OOWS scores at T=180 is the primary outcome measure of the study compared with baseline OOWS scores at T=-30 (30 minutes prior to study medication administration). Reported time frames are in relation to time past since administration of study medications.~Mean post-Naloxone OOWS scores (+/- SEM) were determined for pretreatment groups" (NCT00661674)
Timeframe: Change from baseline in OOWS score at 180 minutes (15 minutes post naloxone administration)
Intervention | units on a scale (OOWS Scale) (Mean) |
---|---|
Placebo | 3.5 |
Palonosetron | 1.0 |
Palonosetron + Hydroxyzine | 0 |
"The SOWS score is composed of 16 subjective symptoms rated on a scale of 0 to 4 (0=not at all, 4=extremely) based on what subjects were experiencing at the time of testing. 15 minutes post naloxone administration coordinates with T = 180 (min) for the entire study session.~The highest score possible (64) would indicate that the individual was experiencing every symptom of opioid withdrawal to the fullest extent possible while the lowest score (0) would indicate that the individual was not experiencing any symptoms of opioid withdrawal.~Mean post-naloxone SOWS scores (+/- SEM) were computed for pretreatment groups: Placebo, palonosetron, and palonosetron with hydroxyzine" (NCT00661674)
Timeframe: Change from baseline in SOWS score at 180 minutes (15 minutes post naloxone administration)
Intervention | units on a scale (SOWS Scale) (Mean) |
---|---|
Placebo | 6.0 |
Palonosetron | 4.0 |
Palonosetron + Hydroxyzine | 3.5 |
7 reviews available for clonidine and Alcohol Abuse
Article | Year |
---|---|
Noradrenergic targets for the treatment of alcohol use disorder.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antag | 2018 |
Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?
Topics: Adrenergic alpha-2 Receptor Agonists; Alcoholism; Clonidine; Dexmedetomidine; Humans; Opioid-Related | 2014 |
[α2-Agonists during withdrawal].
Topics: Adrenergic alpha-2 Receptor Agonists; Alcoholism; Clonidine; Humans; Opioid-Related Disorders; Subst | 2011 |
Drugs as tools for exploring neuroendocrine functions.
Topics: Alcoholism; Clonidine; Depressive Disorder; Desipramine; Female; Growth Hormone; Humans; Insulin; Ma | 1984 |
NIH conference. Alcohol withdrawal and noradrenergic function.
Topics: Alcoholism; Animals; Brain Chemistry; Clonidine; Corticotropin-Releasing Hormone; Epinephrine; Human | 1987 |
Clonidine.
Topics: Alcoholism; Clonidine; Humans; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1987 |
Clonidine and alcohol withdrawal.
Topics: Alcohol Withdrawal Delirium; Alcoholism; Clonidine; Humans; Psychoses, Alcoholic | 1987 |
10 trials available for clonidine and Alcohol Abuse
Article | Year |
---|---|
Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Aged; Alcoholism; Anesthesia; Central Nervous Syste | 2004 |
Effects of clonidine on central and peripheral catecholamine metabolism.
Topics: Aged; Alcoholism; Blood Pressure; Clonidine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ma | 1984 |
Efficacy of clonidine in treatment of alcohol withdrawal state.
Topics: Adult; Aged; Alcoholism; Anxiety; Blood Pressure; Body Temperature; Clonidine; Female; Humans; Male; | 1983 |
Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Alprazolam; Blood Pressure; Clonidine; Diazepam; Dou | 1994 |
Growth hormone response to growth hormone-releasing hormone in early abstinent alcoholic patients.
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Clonidine; Female; Growth Hormone; Growth Hormone-Re | 1993 |
Effect of history of alcoholism or major depression on smoking cessation.
Topics: Adult; Alcohol Drinking; Alcoholism; Clonidine; Comorbidity; Depressive Disorder; Female; Follow-Up | 1993 |
Postoperative alpha 2-adrenergic stimulation attenuates protein catabolism.
Topics: Adrenergic alpha-Agonists; Alcoholism; Blood Proteins; Clonidine; Esophageal Neoplasms; Glucagon; Gl | 1996 |
Clonidine in alcohol withdrawal.
Topics: Adult; Alcoholism; Clinical Trials as Topic; Clonidine; Drug Evaluation; Ethanol; Humans; Male; Midd | 1975 |
Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment.
Topics: Adrenergic alpha-Agonists; Adult; Alcoholism; Catecholamines; Clinical Trials as Topic; Clonidine; D | 1989 |
Is clonidine useful in the treatment of alcohol withdrawal?
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Chlormethiazole; Clinical Trials as Topic; Clonidine | 1989 |
27 other studies available for clonidine and Alcohol Abuse
Article | Year |
---|---|
A Medical Review of Fatal High-G U.S. Aerobatic Accidents.
Topics: Accidents, Aviation; Aerospace Medicine; Alcoholism; Alprazolam; Case-Control Studies; Clonidine; Da | 2019 |
Comparative Evaluation of Partial α2 -Adrenoceptor Agonist and Pure α2 -Adrenoceptor Antagonist on the Behavioural Symptoms of Withdrawal after Chronic Alcohol Administration in Mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Alcoholism; Animals; Anxiety; Be | 2016 |
Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals.
Topics: Adult; Alcoholism; Biomarkers; Case-Control Studies; Citalopram; Clonidine; Dopamine; Female; Human | 2012 |
Extremely long recovery time for the sedative effect of clonidine in male type 1 alcohol-dependent subjects in full sustained remission.
Topics: Adult; Aged; Alcoholism; Blood Pressure; Clonidine; Heart Rate; Humans; Hypnotics and Sedatives; Mal | 2002 |
[Can alcoholic withdrawal delirium be prevented?].
Topics: Alcohol Withdrawal Delirium; Alcoholism; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; | 2003 |
Management of drug and alcohol withdrawal.
Topics: Alcoholism; Benzodiazepines; Clonidine; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; | 2003 |
Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alcoholism; Animals; Clonidine; Conditionin | 2005 |
Management of alcohol withdrawal.
Topics: Adrenergic alpha-Agonists; Alcoholism; Clonidine; Humans; Medicine; Specialization; Substance Withdr | 1995 |
Management of alcohol withdrawal.
Topics: Adrenergic alpha-Agonists; Alcoholism; Anti-Anxiety Agents; Clonidine; Diazepam; Humans; Midazolam; | 1995 |
Alcohol withdrawal: a nationwide survey of inpatient treatment practices.
Topics: Adrenergic beta-Antagonists; Alcoholism; Barbiturates; Benzodiazepines; Chlordiazepoxide; Clonidine; | 1995 |
[Therapeutic experiences with alcohol-related Korsakoff syndrome].
Topics: Adrenergic alpha-Agonists; Adult; Alcohol Withdrawal Delirium; Alcoholism; Anti-Anxiety Agents; Brai | 1999 |
Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence.
Topics: Adult; Aged; Alcoholism; Clonidine; Down-Regulation; Ethanol; Human Growth Hormone; Humans; Male; Mi | 2000 |
[Ambulatory detoxification of alcoholic patients--evaluation of a model project].
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Ambulatory Care; Clonidine; Doxepin; Female; Follow- | 2000 |
[Ambulatory detoxification of alcoholic patients. Results of a model project].
Topics: Alcoholism; Ambulatory Care; Carbamazepine; Clonidine; Doxepin; Germany; Humans; Outcome and Process | 2000 |
Cardiovascular responses to clonidine in alcohol withdrawal: are they related to psychopathology and mental well-being?
Topics: Adrenergic alpha-Agonists; Adult; Affect; Alcoholism; Anxiety; Blood Pressure; Central Nervous Syste | 2000 |
Mr R: a case study of withdrawal.
Topics: Alcoholism; Clonidine; Cocaine; Humans; Male; Methadone; Middle Aged; Neurologic Examination; Opioid | 1992 |
A rating scale for assessment of alcohol withdrawal psychopathology (AWIP).
Topics: Alcohol Withdrawal Delirium; Alcoholism; Carbamazepine; Chlormethiazole; Chlorprothixene; Clonidine; | 1992 |
[Perioperative risk caused by alcohol and/or drug abuse. Which therapy?].
Topics: Adrenergic beta-Antagonists; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Chlormethiazole; Clon | 1990 |
Studies of alpha-2-adrenoceptor function in abstinent alcoholics.
Topics: Adult; Alcoholism; Arousal; Clonidine; Growth Hormone; Humans; Hydrocortisone; Male; Receptors, Adre | 1989 |
Endocrinological studies in alcoholics during withdrawal and after abstinence.
Topics: Adrenocorticotropic Hormone; Adult; Alcoholism; Clonidine; Depressive Disorder; Dexamethasone; Femal | 1989 |
Alpha-2-adrenoceptor function in alcohol withdrawal: a pilot study of the effects of iv. clonidine in alcoholics and normals.
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Blood Pressure; Clonidine; Growth Hormone; Humans; I | 1988 |
The hypothermic response to clonidine is absent in alcohol withdrawal but returns in abstinence.
Topics: Adult; Alcoholism; Body Temperature Regulation; Brain; Clonidine; Ethanol; Humans; Male; Norepinephr | 1988 |
The role of drugs in the treatment of opioid addicts.
Topics: Alcoholism; Anxiety; Clonidine; Dextropropoxyphene; Heroin; Humans; Inactivation, Metabolic; Kinetic | 1986 |
[Changes in the circadian rhythm of urinary cyclic adenosine monophosphate during the alcoholic withdrawal syndrome and related neurobiological correlations].
Topics: Adult; Alcoholism; Circadian Rhythm; Clonidine; Cyclic AMP; Female; Humans; Piracetam; Sleep Initiat | 1985 |
Clonidine in alcohol withdrawal: a clinical report.
Topics: Adult; Alcoholism; Clonidine; Diazepam; Humans; Male; Substance Withdrawal Syndrome | 1987 |
Clonidine in alcohol withdrawal: a pilot study of differential symptom responses following i.v. clonidine.
Topics: Adult; Affective Symptoms; Alcoholism; Clonidine; Humans; Infusions, Intravenous; Male; Substance Wi | 1987 |
[Clonidine--a new possibility in the treatment of drug addicts].
Topics: Adult; Alcoholism; Clonidine; Female; Humans; Substance-Related Disorders | 1986 |